Kenvue Inc. to Issue Dividend of $0.21 (NYSE:KVUE)

Kenvue Inc. (NYSE:KVUE) declared a dividend on Wednesday, January 28th. Shareholders of record on Wednesday, February 11th will be given a dividend of 0.2075 per share on Wednesday, February 25th. The ex-dividend date is Wednesday, February 11th.

Kenvue has a payout ratio of 68.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Kenvue to earn $1.24 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 66.9%.

Kenvue Stock Performance

KVUE stock traded down $0.15 during midday trading on Wednesday, hitting $17.36. 41,702,109 shares of the company traded hands, compared to its average volume of 49,282,582. Kenvue has a twelve month low of $14.02 and a twelve month high of $25.17. The stock has a market capitalization of $33.25 billion, a price-to-earnings ratio of 23.14 and a beta of 0.60. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The business has a 50 day simple moving average of $17.10 and a 200-day simple moving average of $18.08.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The company had revenue of $3.76 billion for the quarter, compared to the consensus estimate of $3.83 billion. During the same period last year, the business posted $0.28 earnings per share. The firm’s revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities research analysts predict that Kenvue will post 1.14 earnings per share for the current year.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.